$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?
11:01am, Tuesday, 17'th Feb 2026
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Henry Schein Q4 Earnings Preview: What's in Store for the Stock?
10:20am, Tuesday, 17'th Feb 2026
HSIC gears up for Q4 results, with revenues seen rising 4.5% and strength across dental, medical and tech segments shaping expectations.
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced a direct data integration between Align Technology's iTero™ intraoral scanners and its core practice management platforms—Den
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program
06:30am, Friday, 06'th Feb 2026
HOUSTON--(BUSINESS WIRE)--The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of trans
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET
06:30am, Thursday, 22'nd Jan 2026
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will
Dilation Capital Management LP Invests $5.11 Million in Henry Schein, Inc. $HSIC
04:48am, Thursday, 22'nd Jan 2026
Dilation Capital Management LP bought a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Com
Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer
10:00am, Thursday, 15'th Jan 2026
IRVINE, Calif.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Foo
Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
09:15pm, Tuesday, 13'th Jan 2026
Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 13'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
07:00am, Monday, 12'th Jan 2026
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointme
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 06'th Jan 2026
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Straumann Holding AG (SAUHY). But which of these two companies is the best opt
Critical Analysis: McKesson (NYSE:MCK) and Henry Schein (NASDAQ:HSIC)
01:26am, Friday, 02'nd Jan 2026
Henry Schein (NASDAQ: HSIC - Get Free Report) and McKesson (NYSE: MCK - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan
02:00pm, Monday, 29'th Dec 2025
Chicago-based Zuckerman Investment Group increased its Henry Schein position by 72,040 shares in the third quarter. The overall position value went up by about $3.38 million from the previous period.
Henry Schein to Participate in the J.P. Morgan Conference in January
06:30am, Monday, 29'th Dec 2025
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will prese
Assenagon Asset Management S.A. Decreases Stock Position in Henry Schein, Inc. $HSIC
03:21am, Thursday, 25'th Dec 2025
Assenagon Asset Management S.A. decreased its holdings in Henry Schein, Inc. (NASDAQ: HSIC) by 52.3% during the third quarter, according to the company in its most recent disclosure with the Securitie
Sign In
Buy HSIC